amlodipine besylate, equivalent to 10mg of amlodipine.
Hypertension, Coronary Artery Disease (CAD), Chronic Stable Angina
It is a calcium channel blocker that relaxes and widens blood vessels.
Known hypersensitivity to dihydropyridines or any of the inactive ingredients.
Yes, at normal doses. Amlodipine is not dialyzable.
Administer with caution. Dosage recommendations have not been established.
Headaches, dizziness, somnolence, palpitations, flushing, abdominal pain, nausea, edema, fatigue.
Leukopenia, thrombocytopenia, hyperglycemia, insomnia, mood altered, hypertonia, hypoesthesia, paraesthesia, neuropathy, peripheral, syncope, dysgeusia, tremor, extrapyramidal disorder, visual impairment, tinnitus, hypotension, vasculitis, cough, dyspnea, rhinitis, change in bowel habits, dry mouth, dyspepsia, gingival hyperplasia, pancreatitis, vomiting, alopecia, hyperhidrosis, discolouration, urticaria, arthralgia, back pain, muscle spasms, myalgia, pollakiuria, micturition disorder, nocturia, gynecomastia, erectile dysfunction, asthenia, malaise, pain, weight increased/decreased.
Strong CYP3A4 inhibitors (ketoconazole, itraconazole, ritonavir), clarithromycin, CYP3A4 inducers (rifampicin, hypericum perforatum), simvastatin, grapefruit juice, mTOR inhibitors (sirolimus, temsirolimus, everolimus).
Safety has not been established. It is only recommended if there is no safer alternative. Amlodipine is transferred into human breast milk.
Seek immediate medical attention.
5mg once daily.
Below 30°C (86°F) and out of reach of children.
Amlodipine reduced revascularization procedures, hospitalizations for angina, and the composite cardiovascular endpoint in patients with CAD.
Amlodipine-based therapy was not significantly different from chlorthalidone-based therapy in terms of fatal CHD or non-fatal MI, the primary endpoint. No significant difference in all-cause mortality between the two groups.
Amlodipine did not increase the risk of mortality or combined mortality and morbidity in patients with heart failure. Increased reports of pulmonary edema.
Amlodipine arrested the progression of carotid intima-media thickening and reduced the combined endpoint of cardiovascular death, MI, stroke, PTCA, coronary artery bypass graft, hospitalization for unstable angina, and worsening congestive heart failure.
2.5mg to 5mg once daily for children aged 6 to 17 years. Doses in excess of 5mg daily have not been studied.
None known.
Consult your doctor, pharmacist, or visit the official website of the manufacturer.